WallStreetZenWallStreetZen

NASDAQ: HSIC
Henry Schein Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HSIC

Based on 11 analysts offering 12 month price targets for Henry Schein Inc

Min Forecast
$64.00-9.63%
Avg Forecast
$88.18+24.52%
Max Forecast
$100.00+41.2%

Should I buy or sell HSIC stock?

Based on 11 analysts offering ratings for Henry Schein Inc.

Buy
Strong Buy
3 analysts 27.27%
Buy
3 analysts 27.27%
Hold
4 analysts 36.36%
Sell
0 analysts 0%
Strong Sell
1 analysts 9.09%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their HSIC stock forecasts and price targets.

HSIC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-06
lockedlocked$00.00+00.00%2026-05-06
lockedlocked$00.00+00.00%2026-04-24
lockedlocked$00.00+00.00%2026-04-15
lockedlocked$00.00+00.00%2026-04-08
Barrington Research
Bottom 1%
1
BuyMaintains$97.00+36.97%2026-02-25
JP Morgan
Bottom 20%
20
Strong BuyMaintains$92.00+29.91%2026-02-25
Wells Fargo
Top 26%
75
HoldMaintains$87.00+22.85%2026-02-25
Leerink Partners
Top 14%
87
HoldMaintains$87.00+22.85%2026-02-24
Baird
Top 24%
77
BuyUpgrades$100.00+41.20%2026-02-23

1 of 2

Forecast return on equity

Is HSIC forecast to generate an efficient return?

Company
24.19%
Industry
-136.01%
Market
167%
HSIC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HSIC forecast to generate an efficient return on assets?

Company
6.99%
Industry
7.13%
HSIC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HSIC earnings per share forecast

What is HSIC's earnings per share in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$5.42+62.83%
Avg 2 year Forecast
$6.00+80.24%
Avg 3 year Forecast
$6.62+98.67%
HSIC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HSIC revenue forecast

What is HSIC's revenue in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$14.0B+4.54%
Avg 2 year Forecast
$14.5B+8.38%
Avg 3 year Forecast
$15.1B+12.48%
HSIC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HSIC earnings growth forecast

How is HSIC forecast to perform vs Medical Distribution companies and vs the US market?

Company
25.67%
Industry
18.52%
Market
34%
HSIC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HSIC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HSIC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HSIC revenue growth forecast

How is HSIC forecast to perform vs Medical Distribution companies and vs the US market?

Company
3.98%
Industry
7.39%
Market
14.07%
HSIC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HSIC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HSIC vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
HSIC$70.82$88.18+24.52%Buy
AHG$1.98N/AN/A
ACH$3.58$3.38-5.73%Buy
EDAP$4.13$10.00+142.13%Buy
COSM$0.33N/AN/A
View Top Medical Distribution Stocks

Henry Schein Stock Forecast FAQ

Is Henry Schein Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: HSIC) stock is to Buy HSIC stock.

Out of 11 analysts, 3 (27.27%) are recommending HSIC as a Strong Buy, 3 (27.27%) are recommending HSIC as a Buy, 4 (36.36%) are recommending HSIC as a Hold, 0 (0%) are recommending HSIC as a Sell, and 1 (9.09%) are recommending HSIC as a Strong Sell.

If you're new to stock investing, here's how to buy Henry Schein stock.

What is HSIC's earnings growth forecast for 2026-2028?

(NASDAQ: HSIC) Henry Schein's forecast annual earnings growth rate of 25.67% is forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 18.52%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34%.

Henry Schein's earnings in 2026 is $395,000,000.On average, 19 Wall Street analysts forecast HSIC's earnings for 2026 to be $617,690,831, with the lowest HSIC earnings forecast at $581,636,178, and the highest HSIC earnings forecast at $655,477,020. On average, 19 Wall Street analysts forecast HSIC's earnings for 2027 to be $683,739,767, with the lowest HSIC earnings forecast at $632,989,852, and the highest HSIC earnings forecast at $743,990,340.

In 2028, HSIC is forecast to generate $753,627,698 in earnings, with the lowest earnings forecast at $688,809,063 and the highest earnings forecast at $832,503,660.

What is HSIC's revenue growth forecast for 2026-2028?

(NASDAQ: HSIC) Henry Schein's forecast annual revenue growth rate of 3.98% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.07%.

Henry Schein's revenue in 2026 is $13,384,000,000.On average, 20 Wall Street analysts forecast HSIC's revenue for 2026 to be $1,593,809,347,187, with the lowest HSIC revenue forecast at $1,523,522,708,118, and the highest HSIC revenue forecast at $1,646,552,805,678. On average, 20 Wall Street analysts forecast HSIC's revenue for 2027 to be $1,652,476,477,042, with the lowest HSIC revenue forecast at $1,575,696,582,824, and the highest HSIC revenue forecast at $1,717,295,111,775.

In 2028, HSIC is forecast to generate $1,714,902,859,878 in revenue, with the lowest revenue forecast at $1,612,149,945,064 and the highest revenue forecast at $1,824,149,029,841.

What is HSIC's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: HSIC) forecast ROA is 6.99%, which is lower than the forecast US Medical Distribution industry average of 7.13%.

What is HSIC's Price Target?

According to 11 Wall Street analysts that have issued a 1 year HSIC price target, the average HSIC price target is $88.18, with the highest HSIC stock price forecast at $100.00 and the lowest HSIC stock price forecast at $64.00.

On average, Wall Street analysts predict that Henry Schein's share price could reach $88.18 by May 6, 2027. The average Henry Schein stock price prediction forecasts a potential upside of 24.52% from the current HSIC share price of $70.82.

What is HSIC's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: HSIC) Henry Schein's current Earnings Per Share (EPS) is $3.33. On average, analysts forecast that HSIC's EPS will be $5.42 for 2026, with the lowest EPS forecast at $5.11, and the highest EPS forecast at $5.75. On average, analysts forecast that HSIC's EPS will be $6.00 for 2027, with the lowest EPS forecast at $5.56, and the highest EPS forecast at $6.53. In 2028, HSIC's EPS is forecast to hit $6.62 (min: $6.05, max: $7.31).

What is HSIC's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: HSIC) forecast ROE is 24.19%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.